凝血酶激活纤溶抑制物的研究进展

被引:1
作者
谢爽
机构
[1] 上海第二医科大学附属瑞金医院上海血液学研究所上海
关键词
凝血酶活纤溶抑制物; 纤维蛋白溶解; 血浆羧基肽酶原B;
D O I
暂无
中图分类号
R341 [];
学科分类号
1001 ;
摘要
凝血酶激活纤溶抑制物 (thrombinactivatedfibrinolysisinhibitor,TAFI)是近年来发现存在于血浆中的一种蛋白酶原 ,属于羧肽酶家族成员。血液凝固时 ,TAFI被凝血酶 血栓调节蛋白 (T TM)复合物激活后 ,可特异性裂解纤维蛋白C 末端赖氨酸残基 ,下调纤溶活性 ,对纤维蛋白溶解有抑制作用。它的发现给纤溶系统增添了新的认识 ,将给临床防治血栓性疾病提供新的思路。本文将围绕TAFI的发现、分子生物学特性和生理功能等作一综述。
引用
收藏
页码:140 / 141
页数:2
相关论文
共 14 条
[1]  
A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor. Wang W,Boffa MB,Bjazar L,et al. Biological Chemistry . 1998
[2]  
Thrombin-acitivatable fibrinolysis inhibitor(TAFI) deficiency is compatible with murine life. Mariko N,Zheng FY,Lei Z,et al. The Journal of Clinical Investigation . 2002
[3]  
Plasma procarboxypeptidase U in men with symptomatic coronary artery disease. Silveira A,Schaffeman K,Goossens F,et al. Thrombosis and Haemostasis . 2000
[4]  
Human procarboxypeptidase B: three-dimensional structure and implications for thrombin-activatable fibrinolysis inhibitor. Barbosa Pereira PJ,Segura-Martin S,Oliva B,et al. Journal of Molecular Biology . 2002
[5]  
Reduced activity of TAFI ( thrombin-activatable fibrinolysis inhibitor ) in acute promyelocytic leukaemia. Meijers JC,Oudi jk EJ,Mosnier LO,et al. British Journal of Haematology . 2000
[6]  
Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms. Zhao L,Morser J,Bajzar L,et al. Thrombosis and Haemostasis . 1998
[7]  
Plasma TAFI antigen variations in healthy subjects. Chetaille P,Alessi MC,Kouassi D,et al. Thrombosis and Haemostasis . 2000
[8]  
Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade,in human plasma. Schatteman KA,Gppssens FJ,Scharpe SS,et al. Clin Chim . 1999
[9]  
Characterization of the gene encoding human TAFI. Boffa MB,Reid S,Joo E,et al. Biochemistry . 1999
[10]  
CPR-Total(TAFI and activated TAFI) levels in plasma/serum of hemophiliacs. Guo X,Okada N,Okada H,et al. Microbiology and Immunology . 2000